References 1 Bioorganic & Medicinal Chemistry Letters (PubMed)Raun et al
Blood serum and urine samples were collected at 2 week intervals
What It Targets Our Tesamorelin + Ipamorelin peptide blendis designed to target: Visceral and central abdominal fat that resists diet and exercise and is linked to cardiometabolic risk. Skinny fat or soft midsections where clients want more definition, not just scale loss. Loss of lean muscle mass, slower recovery, and reduced training capacity in busy, highoutput adults. Metabolic issues such as insulin resistance, unfavorable lipids, or agerelated abdominal obesity in clients already working on lifestyle
Why Sleep Prevents Sickness Sleep loss impacts your immune response and, in turn, your immune system alters your sleep
Use in adipocyte and liver assays to dissect fat-metabolism and glucose-regulation pathways under dual-pulse protocols
Zhao Q, Xu W, Xing L, Lin Z